Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RITE AID Rx SALES LEAP 18% IN FIRST QUARTER TO $146 MIL.; CHAIN OPENS 21 STORES

Executive Summary

Rite Aid Rx sales jumped 18% to $145.8 mil. in the May 31 first quarter compared to $123.3 mil. in the same 1985 period. "During the first quarter, prescription sales strengthened to 37% of drugstore revenues, up from 35.5% in the previous year," the chain stated. Total sales for the retail drug division rose 13.4% to $394 mil. from $347.4 mil., and Rite Aid attributed the division's strong performance to "the continuing deflationary trend in retail pricing." The chain said that for the three months, its rate of inflation declined on an annualized basis from 4.2% to 2.3%. Corporate revenues increased to $418.7 mil. for the quarter, a 14.1% gain over revenues of $367.1 mil. during the same period last year. Net income during the quarter advanced 11.4% to $16.4 mil. from $14.7 mil. in 1985. Excluding income from equity interest in Superdrug and Super Rite Foods net earnings rose 15.7% to $15.8 mil. from $13.7 mil., the chain noted. During the quarter, Rite Aid opened 21 new drugstores and closed three, a net gain of 18 stores. One of the new drugstores was a Drug Palace deep discount unit. Rite Aid now operates 12 Drug Palace stores. Chart omitted.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS010419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel